Skip to main content

OrbiMed Advisors LLC's Form 4 filing

Disc Medicine, Inc. (IRON) · filed Mar 21, 2025

Accession no.
0000947871-25-000333
Filed
Mar 21, 2025, 8:00 PM ET
Trade date
Mar 19-21, 2025
Filing delay
2 days
Rule 10b5-1 plan
Not checked

This filing lists 9 non-derivative transactions. Open-market sales total $2.83M. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
OrbiMed Advisors LLCCIK 0001055951Director
OrbiMed Capital GP VI LLCCIK 0001682115Director
OrbiMed Genesis GP LLCCIK 0001808744Director
OrbiMed Capital GP VIII LLCCIK 0001845804Director

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Mar 19, 2025Common StockSSaleDisposed−13,517$54.02−$730,188.34488,617IndirectDuplicate filing
Mar 19, 2025Common StockSSaleDisposed−20,911$54.02−$1,129,612.22755,933IndirectDuplicate filing
Mar 19, 2025Common StockSSaleDisposed−5,228$54.02−$282,416.56188,981IndirectDuplicate filing
Mar 20, 2025Common StockSSaleDisposed−941$54.01−$50,823.41487,676IndirectDuplicate filing
Mar 20, 2025Common StockSSaleDisposed−1,457$54.01−$78,692.57754,476IndirectDuplicate filing
Mar 20, 2025Common StockSSaleDisposed−364$54.01−$19,659.64188,617IndirectDuplicate filing
Mar 21, 2025Common StockSSaleDisposed−3,412$54.00−$184,248484,264IndirectDuplicate filing
Mar 21, 2025Common StockSSaleDisposed−5,279$54.00−$285,066749,197IndirectDuplicate filing
Mar 21, 2025Common StockSSaleDisposed−1,320$54.00−$71,280187,297IndirectDuplicate filing

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

No transaction price on this filing refers to a footnote.

Read the full filing on SEC EDGAR (opens in a new tab)